These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 8719556)

  • 1. Effect of recombinant human erythropoietin on interleukin-1 beta and interleukin-6 in patients on maintenance hemodialysis.
    Sayinalp N; Erdem Y; Haznedaroğlu IC; Dündar S; Cağlar S; Kirazli S
    Clin Nephrol; 1995 Dec; 44(6):404. PubMed ID: 8719556
    [No Abstract]   [Full Text] [Related]  

  • 2. [Improvement of the quality of life for hemodialysis patients using recombinant human erythropoietin].
    Schaefer RM
    Krankenpfl J; 1988; 26(7-8):317-20. PubMed ID: 3419139
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of recombinant human erythropoietin on soluble interleukin 2 receptor (SIL-2R) levels in haemodialysis patients.
    Altun B; Erdem Y; Haznedaroğlu I; Gürsoy M; Yasavul U; Turgan C; Cağlar S; Kirazli S
    Nephrol Dial Transplant; 1995 Nov; 10(11):2164. PubMed ID: 8643199
    [No Abstract]   [Full Text] [Related]  

  • 4. Interleukin-1beta and recombinant human erythropoietin therapy.
    Takemasa A; Yorioka N
    Clin Nephrol; 1999 Jul; 52(1):61-2. PubMed ID: 10442499
    [No Abstract]   [Full Text] [Related]  

  • 5. Recombinant human erythropoietin resistance in hemodialysis. Effects of paired filtration dialysis.
    Carozzi S; Nasini MG; Santoni O; Tirotta A; Sanna A
    ASAIO J; 1997; 43(5):M535-8. PubMed ID: 9360100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Does aluminum affect the effectiveness of human recombinant erythropoietin in the treatment of anemia in dialyzed patients?].
    Sulková S; Laurincová Z; Kvasnicka J
    Cas Lek Cesk; 1990 Jan; 129(4):113-5. PubMed ID: 2331725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Low doses of recombinant erythropoietin in the treatment of renal anemia in patients on chronic hemodialysis and ambulatory peritoneal dialysis].
    Lashutin SV; Nikolaev AIu; Ermolenko VM; Shutov EV; Bezruk VG; Ivashchenko MA
    Ter Arkh; 1999; 71(6):61-3. PubMed ID: 10420460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maintenance therapy with intravenous iron in hemodialysis patients receiving erythropoietin.
    Kotaki M; Uday K; Henriquez M; Blum S; Dave M
    Clin Nephrol; 1997 Jul; 48(1):63-4. PubMed ID: 9247787
    [No Abstract]   [Full Text] [Related]  

  • 9. Orally administrated Juzen-taiho-to/TJ-48 ameliorates erythropoietin (rHuEPO)-resistant anemia in patients on hemodialysis.
    Nakamoto H; Mimura T; Honda N
    Hemodial Int; 2008 Oct; 12 Suppl 2():S9-S14. PubMed ID: 18837771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Erythropoietin, aluminum and renal anemia].
    Schaefer M; Heidland A
    Dtsch Med Wochenschr; 1990 Jun; 115(22):878-9. PubMed ID: 2347300
    [No Abstract]   [Full Text] [Related]  

  • 11. Serial estimation of serum interleukin 6 during treatment with recombinant human erythropoietin in patients with the anemia of rheumatoid arthritis.
    Jongen-Lavrencic M; Swaak AJ; Vreugdenhil G
    J Rheumatol; 1993 Jul; 20(7):1253-5. PubMed ID: 8371234
    [No Abstract]   [Full Text] [Related]  

  • 12. [Erythropoietin and dialyzed patients].
    Kreis H
    Rev Prat; 1989 Dec; 39(28):2530-1. PubMed ID: 2602881
    [No Abstract]   [Full Text] [Related]  

  • 13. Prevalence and severity of anemia in pediatric hemodialysis patients.
    Azhir A; Nasiri J; Gheisari A
    Saudi Med J; 2007 Feb; 28(2):249-53. PubMed ID: 17268705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evolution of medical practice in the care of anemia amd the use of erythropoietin in chronic renal insufficiency hemodialysis in the past six years].
    Canaud B; Richard A; Fagnani F; Moreau-Defarges T; Guillon P
    Nephrologie; 2002; 23(3):123-30. PubMed ID: 12087809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secondary hyperparathyroidism as cause of resistance to treatment with erythropoietin: effect of parathyroidectomy.
    Goicoechea M; Gomez-Campdera F; Polo JR; Tejedor A; Ruiz MA; Vazquez I; Verde E; Valderrabano F
    Clin Nephrol; 1996 Jun; 45(6):420-1. PubMed ID: 8793241
    [No Abstract]   [Full Text] [Related]  

  • 16. [The after effect of r-HuEPO in treating anemic hemodialysis patients].
    Chu JQ
    Zhonghua Hu Li Za Zhi; 1994 Feb; 29(2):78-9. PubMed ID: 7788758
    [No Abstract]   [Full Text] [Related]  

  • 17. [Study of various factors that could have an impact on the treatment with erythropoietin of hemodialysis anemia].
    Fernández-Gallego J; Ramos B; Ruiz A; Contreras J; Alvarez Bustos G; López de Novales E
    Nefrologia; 2000; 20(2):164-70. PubMed ID: 10853198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of human recombinant erythropoietin treatment on erythrocyte delta-aminolevulinic acid dehydratase in patients on maintenance hemodialysis.
    Djordjević VB; Pavlović D; Pejović M; Lecić N; Koraćević D; Djordjević V; Stefanović V
    Nephron; 1993; 65(3):497-8. PubMed ID: 8290015
    [No Abstract]   [Full Text] [Related]  

  • 19. The effect of ultrapure dialysate on improving renal anemia.
    Go I; Takemoto Y; Tsuchida K; Sugimura K; Nakatani T
    Osaka City Med J; 2007 Jun; 53(1):17-23. PubMed ID: 17867630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of anemia on treatment of malnutrition in patients on hemodialysis.
    Paskalev E
    Nephron; 2000 Oct; 86(2):215-6. PubMed ID: 11015006
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.